Breaking News Instant updates and real-time market news.

SIOX

Sio Gene Therapies

$2.29 /

+0.1 (+4.57%)

07:04
06/09/21
06/09
07:04
06/09/21
07:04

Sio Gene Therapies reports Q4 EPS (5c), consensus (17c)

Pavan Cheruvu, CEO of Sio Gene Therapies said, "The positive data recently shared from our Phase 1/2 study of AXO-AAV-GM1, together with our industry-leading position in clinical enrollment and investment in earlier diagnosis, give us renewed momentum as we aim to advance this investigational therapy towards commercialization. In the second half of 2021, we will present 12-month follow-up data on safety, biomarkers, and clinical efficacy from the low-dose cohort of the GM1 gangliosidosis program. We expect these data, as well as a planned regulatory meeting with the FDA expected in the first half of 2022, will help define our registrational pathway in GM1 gangliosidosis. We have confidence in AXO-AAV-GM1 as well as our two other clinical-stage candidates in Tay-Sachs/Sandhoff disease and Parkinson's disease, and look forward to several major milestones across our three programs during this fiscal year. In parallel, we are continuing to build our preclinical and analytical development capabilities in our growing laboratory in Research Triangle Park, and are conducting a search and evaluation process for promising genetic medicines that may expand our pipeline with new product candidates in the years ahead. Our strengthened balance sheet leaves us well-positioned to develop first-in-class and best-in-class gene therapy product candidates in our current pipeline, while also investing in exciting new, biology-driven opportunities in areas of significant unmet patient need."

SIOX Sio Gene Therapies
$2.29 /

+0.1 (+4.57%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Initiation
Oriental Land initiated with an Overweight at JPMorgan » 07:26
10/21/21
10/21
07:26
10/21/21
07:26
OLCLY

Oriental Land

$32.09 /

+1.05 (+3.38%)

JPMorgan analyst Ryota…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OLCLY Oriental Land
$32.09 /

+1.05 (+3.38%)

08/25/21 Citi
Oriental Land upgraded to Neutral from Sell at Citi
Recommendations
Knight-Swift price target raised to $65 from $60 at KeyBanc » 07:26
10/21/21
10/21
07:26
10/21/21
07:26
KNX

Knight-Swift

$54.33 /

+3.535 (+6.96%)

KeyBanc analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

07:10 Today Susquehanna
Knight-Swift price target raised to $59 from $51 at Susquehanna
07:03 Today Baird
Knight-Swift price target raised to $65 from $57 at Baird
09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 Cowen
Knight-Swift upgraded to Outperform at Cowen on truckers' pricing power
KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

KNX Knight-Swift
$54.33 /

+3.535 (+6.96%)

Hot Stocks
Trump Media & Technology Group to merge with Digital World Acquisition » 07:25
10/21/21
10/21
07:25
10/21/21
07:25
DWAC

Digital World Acquisition

$9.96 /

-0.025 (-0.25%)

Shares of Digital World…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DWAC Digital World Acquisition
$9.96 /

-0.025 (-0.25%)

Hot Stocks
ALX Oncology doses first patient in ASPEN-05 study of evorpacept » 07:25
10/21/21
10/21
07:25
10/21/21
07:25
ALXO

ALX Oncology

$55.00 /

+1.11 (+2.06%)

ALX Oncology Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALXO ALX Oncology
$55.00 /

+1.11 (+2.06%)

ALXO ALX Oncology
$55.00 /

+1.11 (+2.06%)

09/29/21 Stifel
ALX Oncology initiated with a Buy at Stifel
07/05/21 Piper Sandler
ALX Oncology update for ALX148 'incrementally positive,' says Piper Sandler
05/04/21 Credit Suisse
ALX Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
ALX Oncology assumed with an Outperform at Credit Suisse
ALXO ALX Oncology
$55.00 /

+1.11 (+2.06%)

  • 13
    Jan
  • 10
    Dec
ALXO ALX Oncology
$55.00 /

+1.11 (+2.06%)

Earnings
Trinity Industries reports Q3 adjusted EPS 29c, consensus 18c » 07:25
10/21/21
10/21
07:25
10/21/21
07:25
TRN

Trinity Industries

$29.51 /

+0.85 (+2.97%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRN Trinity Industries
$29.51 /

+0.85 (+2.97%)

TRN Trinity Industries
$29.51 /

+0.85 (+2.97%)

07/26/21 Susquehanna
Susquehanna upgrades Trinity Industries on improving rail equipment fundamentals
07/26/21 Susquehanna
Trinity Industries upgraded to Positive from Neutral at Susquehanna
06/11/21 OTR Global
Railcar maker view improved to Positive from Mixed at OTR Global
02/25/21 Wells Fargo
Trinity Industries price target raised to $35 from $30 at Wells Fargo
TRN Trinity Industries
$29.51 /

+0.85 (+2.97%)

Upgrade
Ascendas Real Estate upgraded to Overweight from Neutral at JPMorgan » 07:25
10/21/21
10/21
07:25
10/21/21
07:25
ACDSF

Ascendas Real Estate

$2.26 /

-0.004 (-0.18%)

JPMorgan analyst Mervin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACDSF Ascendas Real Estate
$2.26 /

-0.004 (-0.18%)

03/23/21 Goldman Sachs
Ascendas Real Estate initiated with a Buy at Goldman Sachs
Hot Stocks
ChampionX announces launch of Spotlight EDGE » 07:24
10/21/21
10/21
07:24
10/21/21
07:24
CHX

ChampionX

$26.27 /

-0.105 (-0.40%)

ChampionX Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHX ChampionX
$26.27 /

-0.105 (-0.40%)

CHX ChampionX
$26.27 /

-0.105 (-0.40%)

09/17/21 Goldman Sachs
ChampionX initiated with a Sell at Goldman Sachs
09/13/21 Citi
Citi positive on oilfield services, upgrades Liberty to Buy, RPC to Neutral
08/12/21 Citi
ChampionX named top SMID pick in NA Oil Services at Citi
07/02/21 Stifel
ChampionX price target raised to $30 from $26 at Stifel
CHX ChampionX
$26.27 /

-0.105 (-0.40%)

Recommendations
Winnebago price target raised to $85 from $80 at KeyBanc » 07:23
10/21/21
10/21
07:23
10/21/21
07:23
WGO

Winnebago

$69.95 /

-2.35 (-3.25%)

KeyBanc analyst Brett…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WGO Winnebago
$69.95 /

-2.35 (-3.25%)

WGO Winnebago
$69.95 /

-2.35 (-3.25%)

06:49 Today BMO Capital
Winnebago price target raised to $115 from $100 at BMO Capital
10/01/21 BMO Capital
Winnebago price target raised to $100 from $90 at BMO Capital
07/01/21 Raymond James
Winnebago initiated with Market Perform on margin concerns at Raymond James
07/01/21 Raymond James
Winnebago initiated with a Market Perform at Raymond James
WGO Winnebago
$69.95 /

-2.35 (-3.25%)

WGO Winnebago
$69.95 /

-2.35 (-3.25%)

Hot Stocks
CareDx announces completion of OrganX longitudinal study of AlloSure » 07:23
10/21/21
10/21
07:23
10/21/21
07:23
CDNA

CareDx

$72.00 /

-1.71 (-2.32%)

CareDx congratulated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDNA CareDx
$72.00 /

-1.71 (-2.32%)

CDNA CareDx
$72.00 /

-1.71 (-2.32%)

08/31/21 Craig-Hallum
Natera seeks to challenge CareDx franchise with launch, says Craig-Hallum
07/30/21 Piper Sandler
CareDx price target raised to $110 from $100 at Piper Sandler
07/20/21
Fly Intel: Top five analyst initiations
07/20/21 BTIG
CareDx assumed with a Buy at BTIG
CDNA CareDx
$72.00 /

-1.71 (-2.32%)

  • 21
    Jan
CDNA CareDx
$72.00 /

-1.71 (-2.32%)

Earnings
Chart Industries reports Q3 adjusted EPS 55c, consensus 84c » 07:21
10/21/21
10/21
07:21
10/21/21
07:21
GTLS

Chart Industries

$181.16 /

-0.95 (-0.52%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTLS Chart Industries
$181.16 /

-0.95 (-0.52%)

GTLS Chart Industries
$181.16 /

-0.95 (-0.52%)

10/18/21 BofA
Chart Industries downgraded to Neutral from Buy at BofA on valuation
10/18/21 BofA
Chart Industries downgraded to Neutral from Buy at BofA
10/12/21 Morgan Stanley
Chart Industries price target raised to $200 from $165 at Morgan Stanley
10/05/21 Raymond James
Chart Industries downgraded to Market Perform from Outperform at Raymond James
GTLS Chart Industries
$181.16 /

-0.95 (-0.52%)

GTLS Chart Industries
$181.16 /

-0.95 (-0.52%)

Hot Stocks
Medipharm Labs appoints Bryan Howcroft as CEO » 07:21
10/21/21
10/21
07:21
10/21/21
07:21
MEDIF

Medipharm Labs

/

+

MediPharm Labs announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
/

+

MEDIF Medipharm Labs
/

+

08/16/21 Alliance Global Partners
Medipharm Labs price target lowered to C$0.80 from C$1 at Alliance Global Partners
05/18/21 Canaccord
Medipharm Labs price target lowered to C$0.75 from C$1.00 at Canaccord
05/18/21 Alliance Global Partners
Medipharm Labs price target lowered to C$1 from C$1.25 at Alliance Global
04/16/21 BMO Capital
Medipharm Labs initiated with a Market Perform at BMO Capital
MEDIF Medipharm Labs
/

+

Recommendations
Cooper Companies price target lowered to $465 from $476 at KeyBanc » 07:21
10/21/21
10/21
07:21
10/21/21
07:21
COO

Cooper Companies

$410.69 /

+8.13 (+2.02%)

KeyBanc analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$410.69 /

+8.13 (+2.02%)

COO Cooper Companies
$410.69 /

+8.13 (+2.02%)

09/03/21 Stifel
Cooper Companies price target raised to $475 from $450 at Stifel
09/03/21 Citi
Cooper Companies price target raised to $453 from $400 at Citi
09/03/21 Oppenheimer
Cooper Companies price target raised to $475 from $405 at Oppenheimer
09/03/21 KeyBanc
Cooper Companies price target raised to $476 from $444 at KeyBanc
COO Cooper Companies
$410.69 /

+8.13 (+2.02%)

COO Cooper Companies
$410.69 /

+8.13 (+2.02%)

Hot Stocks
Can-Fite BioPharma says journal publishes article on namodenoson for NASH » 07:20
10/21/21
10/21
07:20
10/21/21
07:20
CANF

Can-Fite BioPharma

$1.56 /

-0.005 (-0.32%)

Can-Fite BioPharma …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CANF Can-Fite BioPharma
$1.56 /

-0.005 (-0.32%)

CANF Can-Fite BioPharma
$1.56 /

-0.005 (-0.32%)

06/15/21 Alliance Global Partners
Can-Fite BioPharma initiated with a Buy at Alliance Global Partners
CANF Can-Fite BioPharma
$1.56 /

-0.005 (-0.32%)

Hot Stocks
Red White & Bloom Brands appoints Colby De Zen to board » 07:20
10/21/21
10/21
07:20
10/21/21
07:20
RWBYF

Red White & Bloom Brands

/

+

ed White & Bloom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RWBYF Red White & Bloom Brands
/

+

RWBYF Red White & Bloom Brands
/

+

Initiation
Magnum Opus Acquisition initiated with an Overweight at Cantor Fitzgerald » 07:19
10/21/21
10/21
07:19
10/21/21
07:19
OPA

Magnum Opus Acquisition

$9.90 /

-0.02 (-0.20%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPA Magnum Opus Acquisition
$9.90 /

-0.02 (-0.20%)

OPA Magnum Opus Acquisition
$9.90 /

-0.02 (-0.20%)

OPA Magnum Opus Acquisition
$9.90 /

-0.02 (-0.20%)

Hot Stocks
Xebec Adsorption receives EU research grant for 1 MW electrolyser system » 07:18
10/21/21
10/21
07:18
10/21/21
07:18
XEBEF

Xebec Adsorption

$2.33 /

-0.13 (-5.28%)

Xebec Adsorption…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XEBEF Xebec Adsorption
$2.33 /

-0.13 (-5.28%)

XEBEF Xebec Adsorption
$2.33 /

-0.13 (-5.28%)

08/16/21 Desjardins
Xebec Adsorption price target lowered to C$5 from C$6.50 at Desjardins
08/13/21 Stifel
Xebec Adsorption price target lowered to C$4.25 from C$5 at Stifel
08/13/21 TD Securities
Xebec Adsorption downgraded to Hold from Speculative Buy at TD Securities
08/13/21 Raymond James
Xebec Adsorption downgraded to Market Perform from Outperform at Raymond James
XEBEF Xebec Adsorption
$2.33 /

-0.13 (-5.28%)

Hot Stocks
Nice's Digital Evidence solution selected by Charleston County Sheriff's Office » 07:18
10/21/21
10/21
07:18
10/21/21
07:18
NICE

Nice

$275.94 /

-0.24 (-0.09%)

Nice's Investigate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NICE Nice
$275.94 /

-0.24 (-0.09%)

NICE Nice
$275.94 /

-0.24 (-0.09%)

09/09/21 JMP Securities
Nice price target raised to $343 from $302 at JMP Securities
08/06/21 Citi
Nice price target raised to $328 from $320 at Citi
07/19/21 Jefferies
Jefferies says Zoom deal could drive short-term weakness in RingCentral and Nice
07/06/21 RBC Capital
Nice upgraded to Outperform on cloud platform growth at RBC
NICE Nice
$275.94 /

-0.24 (-0.09%)

NICE Nice
$275.94 /

-0.24 (-0.09%)

Earnings
Interpublic Group reports Q3 EPS 60c, consensus 49c » 07:18
10/21/21
10/21
07:18
10/21/21
07:18
IPG

Interpublic Group

$38.01 /

-0.25 (-0.65%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

10/05/21 JPMorgan
Interpublic Group price target raised to $43 from $38 at JPMorgan
07/22/21 BofA
Interpublic Group upgraded to Neutral at BofA after 'impressive' results
07/22/21 BMO Capital
Interpublic Group price target raised to $38 from $34 at BMO Capital
07/22/21 BofA
Interpublic Group upgraded to Neutral from Underperform at BofA
IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

IPG Interpublic Group
$38.01 /

-0.25 (-0.65%)

Recommendations
Deutsche 'intrigued' by strategic possibilities of PayPal buying Pinterest » 07:18
10/21/21
10/21
07:18
10/21/21
07:18
PYPL

PayPal

$258.00 /

-13.63 (-5.02%)

, PINS

Pinterest

$62.68 /

+7.085 (+12.74%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

10/20/21 Bernstein
PayPayl, Pinterest 'is a match NOT made in heaven,' says Bernstein
10/20/21 Keefe Bruyette
Pinterest purchase 'can make sense' for PayPal, says Keefe Bruyette
10/20/21 Cowen
Potential Pinterest deal dovetails with PayPal's Super App strategy, says Cowen
10/20/21 Baird
PayPal deal for Pinterest could help accelerate super app ambitions, says Baird
PINS Pinterest
$62.68 /

+7.085 (+12.74%)

10/20/21 Bernstein
PayPayl, Pinterest 'is a match NOT made in heaven,' says Bernstein
10/20/21 Keefe Bruyette
Pinterest purchase 'can make sense' for PayPal, says Keefe Bruyette
10/20/21 Cowen
Potential Pinterest deal dovetails with PayPal's Super App strategy, says Cowen
10/20/21 Baird
PayPal deal for Pinterest could help accelerate super app ambitions, says Baird
PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

PYPL PayPal
$258.00 /

-13.63 (-5.02%)

PINS Pinterest
$62.68 /

+7.085 (+12.74%)

Recommendations
Lam Research price target lowered to $700 from $715 at UBS » 07:17
10/21/21
10/21
07:17
10/21/21
07:17
LRCX

Lam Research

$566.24 /

-3.95 (-0.69%)

UBS analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

07:12 Today Susquehanna
Lam Research price target lowered to $590 from $690 at Susquehanna
07:10 Today Deutsche Bank
Lam Research price target lowered to $650 from $700 at Deutsche Bank
06:46 Today Mizuho
Lam Research price target lowered to $700 from $725 at Mizuho
06:22 Today Barclays
Lam Research price target lowered to $625 from $700 at Barclays
LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

LRCX Lam Research
$566.24 /

-3.95 (-0.69%)

Hot Stocks
BeyondSpring announces first patient treated in Phase 2 study of plinabulin » 07:17
10/21/21
10/21
07:17
10/21/21
07:17
BYSI

BeyondSpring

$16.78 /

+0.16 (+0.96%)

BeyondSpring announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYSI BeyondSpring
$16.78 /

+0.16 (+0.96%)

BYSI BeyondSpring
$16.78 /

+0.16 (+0.96%)

09/20/21 H.C. Wainwright
BeyondSpring price target lowered to $65 from $100 at H.C. Wainwright
09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
BYSI BeyondSpring
$16.78 /

+0.16 (+0.96%)

  • 19
    Nov
BYSI BeyondSpring
$16.78 /

+0.16 (+0.96%)

BYSI BeyondSpring
$16.78 /

+0.16 (+0.96%)

Hot Stocks
CynergisTek gets six-figure cybersecurity service agreement with university » 07:17
10/21/21
10/21
07:17
10/21/21
07:17
CTEK

CynergisTek

$1.83 /

+0.03 (+1.67%)

CynergisTek announces a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTEK CynergisTek
$1.83 /

+0.03 (+1.67%)

CTEK CynergisTek
$1.83 /

+0.03 (+1.67%)

CTEK CynergisTek
$1.83 /

+0.03 (+1.67%)

Hot Stocks
AutoNation CEO says 'demand continues to outpace supply for new vehicles' » 07:16
10/21/21
10/21
07:16
10/21/21
07:16
AN

AutoNation

$117.11 /

+1.67 (+1.45%)

Mike Jackson,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

09/28/21 Morgan Stanley
AutoNation upgraded to Equal Weight from Underweight at Morgan Stanley
07/20/21 Truist
AutoNation price target raised to $110 from $100 at Truist
07/16/21 BofA
AutoNation price target raised to $171 from $161 at BofA
04/22/21
Fly Intel: Top five analyst upgrades
AN AutoNation
$117.11 /

+1.67 (+1.45%)

AN AutoNation
$117.11 /

+1.67 (+1.45%)

Earnings
Renalytix reports FY21 EPS (43c) vs (16c) last year » 07:15
10/21/21
10/21
07:15
10/21/21
07:15
RNLX

Renalytix

$26.35 /

+1.78 (+7.24%)

Reports FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RNLX Renalytix
$26.35 /

+1.78 (+7.24%)

RNLX Renalytix
$26.35 /

+1.78 (+7.24%)

10/04/21 Guggenheim
Renalytix initiated with a Buy at Guggenheim
07/02/21 Berenberg
Renalytix AI initiated with a Buy at Berenberg
04/22/21 Investec
Renalytix AI upgraded to Buy from Hold at Investec
04/08/21 Stifel
Renalytix presented survey suggests favorable view on KidneyIntelX, says Stifel
RNLX Renalytix
$26.35 /

+1.78 (+7.24%)

Earnings
Rogers Communications reports Q3 adjusted EPS C$1.03 vs. C$1.08 last year » 07:15
10/21/21
10/21
07:15
10/21/21
07:15
RCI

Rogers Communications

$49.66 /

+0.79 (+1.62%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCI Rogers Communications
$49.66 /

+0.79 (+1.62%)

RCI Rogers Communications
$49.66 /

+0.79 (+1.62%)

10/12/21 BMO Capital
Rogers Communications price target lowered to $68 from $72 at BMO Capital
10/05/21 JPMorgan
Rogers underperformance brings attractive entry point, says JPMorgan
09/17/21 Morgan Stanley
Morgan Stanley ups Shaw target to C$40.50, names as catalyst driven idea
09/09/21 TD Securities
Rogers Communications resumed with a Buy at TD Securities
RCI Rogers Communications
$49.66 /

+0.79 (+1.62%)

RCI Rogers Communications
$49.66 /

+0.79 (+1.62%)

RCI Rogers Communications
$49.66 /

+0.79 (+1.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.